Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) Equity Average (2020 - 2025)

LifeStance Health (LFST) has disclosed Equity Average for 6 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Equity Average rose 4.52% to $1.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 billion, a 4.52% increase, with the full-year FY2025 number at $1.5 billion, up 3.2% from a year prior.
  • Equity Average was $1.5 billion for Q4 2025 at LifeStance Health, up from $1.5 billion in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.5 billion in Q4 2021 to a low of $976.8 million in Q1 2021.
  • A 5-year average of $1.5 billion and a median of $1.5 billion in 2023 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: skyrocketed 58.04% in 2022, then dropped 5.49% in 2024.
  • LifeStance Health's Equity Average stood at $1.5 billion in 2021, then decreased by 1.28% to $1.5 billion in 2022, then decreased by 5.45% to $1.4 billion in 2023, then fell by 0.02% to $1.4 billion in 2024, then rose by 4.52% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for LFST's Equity Average are $1.5 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025).